To determine US diabetes screening estimates in Whites, Blacks, Hispanics, Asians, Native Hawaiians/Pacific Islanders, American Indians/Alaska Natives, and Others at the national, regional, and state level. In this study of 2011, 2013, 2015, and 2017 Behavioral Risk Factor Surveillance System data, we used logistic regression results to generate national, regional, and state screening marginal probabilities (average adjusted predictions (AAPs)) for each race in the two American Diabetes Association recommended screening groups1: asymptomatic overweight/obese people <45y with ≥1 diabetes risk factor and2 people ≥45y. Even after adjusting for sociodemographic and clinical factors, significant racial disparities in screening (p-value<.05) persist at all three geographic levels. Asians had the worst national, regional, and state level AAPs of all the races. Across all races, the Northeast had the highest regional screening levels (regional AAP: 48.4–78.58%) while the West had the lowest (regional AAP: 41.98–75.18%). Study findings indicate that sociodemographic and clinical factors do not fully explain racial disparities in diabetes screening. Further research on clinician and patient attitudes towards diabetes screening are warranted in order to design and implement initiatives in US areas where certain racial groups have particularly low diabetes screening levels. •Racial disparity in diabetes screening exists at the national level in the US.•Little known about whether it extends to the regional and state level.•Asians have lowest diabetes screening of all races at all geographic levels.•Racial disparity in diabetes screening varies between regions and states.